Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases*
暂无分享,去创建一个
Toru Kita | Osamu Nureki | Takeshi Kimura | O. Nureki | Takeshi Kimura | T. Kita | H. Kondo | K. Okawa | H. Horiuchi | S. Fukai | Shuya Fukai | Katsuya Okawa | Tomoyuki Ikeda | R. Shirakawa | M. Kawato | Ryutaro Shirakawa | Mitsunori Kawato | Tomohito Higashi | Hirokazu Kondo | Tomoyuki Ikeda | Ei Nakayama | Hisanori Horiuchi | T. Higashi | E. Nakayama | Mitsunori Kawato
[1] K. Kelly,et al. Activation of the RalGEF/Ral Pathway Promotes Prostate Cancer Metastasis to Bone , 2007, Molecular and Cellular Biology.
[2] P. Harris,et al. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. , 1997, Human molecular genetics.
[3] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[4] S. Adam,et al. Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells , 2006, Current Biology.
[5] E. Martegani,et al. Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase. , 2007, Experimental cell research.
[6] D. Geschwind,et al. Cloning, genomic structure, and expression profiles of TULIP1 (GARNL1), a brain-expressed candidate gene for 14q13-linked neurological phenotypes, and its murine homologue. , 2004, Genomics.
[7] Axel T Brunger,et al. Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex , 2003, The EMBO journal.
[8] A. F. Castro,et al. Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner* , 2003, Journal of Biological Chemistry.
[9] D. Andres,et al. A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. , 2000, The Journal of biological chemistry.
[10] L. Feig,et al. Characterization of a GTPase-activating protein for the Ras-related Ral protein. , 1991, The Journal of biological chemistry.
[11] R. Weinberg,et al. Characterization of a guanine nucleotide dissociation stimulator for a ras‐related GTPase. , 1993, The EMBO journal.
[12] L. J. van 't Veer,et al. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.
[13] J. Camonis,et al. Bridging Ral GTPase to Rho Pathways , 1995, The Journal of Biological Chemistry.
[14] T. Urano,et al. Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.
[15] L. Quilliam,et al. Identification and Characterization of a New Family of Guanine Nucleotide Exchange Factors for the Ras-related GTPase Ral* , 2000, The Journal of Biological Chemistry.
[16] G. Stamp,et al. RalGDS is required for tumor formation in a model of skin carcinogenesis. , 2005, Cancer cell.
[17] K. Inoki,et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.
[18] A. Iwamatsu,et al. The exocyst complex binds the small GTPase RalA to mediate filopodia formation , 2002, Nature Cell Biology.
[19] S. Demo,et al. ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.
[20] R. Wolthuis,et al. RalGEF2, a Pleckstrin Homology Domain Containing Guanine Nucleotide Exchange Factor for Ral* , 2000, The Journal of Biological Chemistry.
[21] R. Wolthuis,et al. Ras-dependent activation of the small GTPase Ral , 1998, Current Biology.
[22] A. Wittinghofer,et al. The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues , 2008, The EMBO journal.
[23] M. White,et al. Ral GTPases: corrupting the exocyst in cancer cells. , 2005, Trends in cell biology.
[24] K. Inoki,et al. Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity , 2004, Molecular and Cellular Biology.
[25] M. Webb,et al. Interaction of GTPase activating proteins (GAPs) with p21ras measured by a novel fluorescence anisotropy method. Essential role of Arg-903 of GAP in activation of GTP hydrolysis on p21ras. , 1993, The Journal of biological chemistry.
[26] C. Der,et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. , 2002, Genes & development.
[27] P. Crino,et al. The tuberous sclerosis complex. , 2006, The New England journal of medicine.
[28] I. Vetter,et al. The GTPase-activating protein Rap1GAP uses a catalytic asparagine , 2004, Nature.
[29] A. Wittinghofer,et al. Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity , 1992, Molecular and cellular biology.
[30] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[31] M. White,et al. Ral GTPases and cancer: linchpin support of the tumorigenic platform , 2008, Nature Reviews Cancer.
[32] O. Nureki,et al. Regulation of Platelet Dense Granule Secretion by the Ral GTPase-Exocyst Pathway* , 2008, Journal of Biological Chemistry.
[33] L. Feig. Ral-GTPases: approaching their 15 minutes of fame. , 2003, Trends in cell biology.
[34] S. Gridley,et al. Adipocytes contain a novel complex similar to the tuberous sclerosis complex. , 2006, Cellular signalling.
[35] M. White,et al. RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival , 2003, EMBO reports.
[36] D. Theodorescu,et al. Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer , 2007, Clinical Cancer Research.
[37] R. Weinberg,et al. Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.
[38] Alfred Wittinghofer,et al. GEFs and GAPs: Critical Elements in the Control of Small G Proteins , 2007, Cell.
[39] E. Hafen,et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.
[40] W. Hahn,et al. The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase , 2007, Cell.
[41] J. Blenis,et al. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.
[42] C. Walker,et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning , 2006, The Journal of cell biology.
[43] O. Nureki,et al. Biochemical Characterization of the Rho GTPase-regulated Actin Assembly by Diaphanous-related Formins, mDia1 and Daam1, in Platelets* , 2008, Journal of Biological Chemistry.
[44] C. Rossé,et al. The exocyst is a Ral effector complex , 2002, Nature Cell Biology.
[45] M. White,et al. RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival , 2006, Cell.
[46] M. Shipitsin,et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.
[47] M. Larsen,et al. The Brain Exocyst Complex Interacts with RalA in a GTP-dependent Manner , 2001, The Journal of Biological Chemistry.
[48] B. Edgar,et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.
[49] R. Wolthuis,et al. Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.
[50] S. Cantor,et al. Identification and Characterization of Ral-Binding Protein 1, a Potential Downstream Target of Ral GTPases , 2022 .